Look, if you’re just chasing tickers after they spike, you’re always going to be late.
Real traders are already reacting to Nvidia’s latest move.
The U.S. just cleared them to resume AI chip sales to China.
That’s a big reversal—and the kind of setup I’ve trained my system to catch.
When my alerts flag something like this, I pay attention.
Now the opportunity is back.
[Tap here to see how we catch these moves early]
You don’t need hype. You need timing.
Let’s trade smarter.
Tim
3 Big Short Interest Names With Bullish Setups
Written by Ryan Hasson. Published 9/22/2025.
Key Points
- Market momentum remains strong, with speculation rising but not at extreme levels, creating room for further upside.
- HIMS, DLO, and TEM each combine bullish technical setups with elevated short interest, making them prime candidates for potential squeezes.
- While speculation may eventually cool, the current backdrop supports momentum, and these names stand out as high-upside potential opportunities.
Last week, several heavily shorted, momentum-driven stocks broke out strongly, riding speculation as the broader market hit fresh highs. While this euphoria inevitably raises questions about sustainability, history shows that momentum can carry far beyond what skeptics expect.
As Warren Buffett famously said, "The market can remain irrational longer than investors can stay solvent."
Free SMS Stock Alerts from MarketBeat (Ad)
Your account is not currently signed up for MarketBeat's free Monday morning stock ideas. Our team is going to be releasing an important pick on Monday morning and we want to make sure that you are able to see it.
Add your name to the distribution list hereThe Fear & Greed Index currently sits at 62, reflecting greed but not yet extreme levels. Likewise, the SPDR S&P 500 ETF Trust (NYSEARCA: SPY) holds an RSI of 71—stretched, but not yet at a peak. In other words, momentum may still have room to run. Against this backdrop, three heavily shorted names stand out with technical setups that could fuel further upside if sentiment remains supportive.
HIMS: A Retail Favorite on the Edge of a Breakout
This year, Hims & Hers Health (NYSE: HIMS) has been in the spotlight, drawing scrutiny from Washington regulators over its advertising practices and the telehealth distribution of GLP-1 weight-loss drugs. Last week, the FDA posted more than 100 letters to companies, including Hims & Hers, as part of a broader crackdown on pharmaceutical corporations.
Despite these potential headwinds, the stock's performance has been extraordinary. Shares are up 139% year-to-date and 259% over the past 12 months.
Technically, HIMS has been consolidating since May in a broad range between $40 support and $65 resistance. On Friday, the stock pushed toward the $60 level, hinting at a potential retest of its upper boundary.
What makes this setup especially compelling is the 38% short interest—over 74 million shares sold short. A decisive move above $65 could force a powerful short squeeze, adding fuel to the stock's already strong momentum.
DLO: Strong Earnings Meet Heavy Shorts
DLocal Limited (NASDAQ: DLO), a fintech firm specializing in cross-border payments in emerging markets, has flown under the radar for much of its history. That changed after its latest earnings release, which delivered a convincing beat on both revenue and earnings.
The strong results helped DLO break out of a long base, with shares now up nearly 40% year-to-date. Wall Street has taken notice, lifting the consensus price target from $12.45 three months ago to $14, along with multiple upgrades.
But the technical picture is only part of the story. DLO carries a 23.4% short interest—equivalent to nearly 15 million shares. The stock trades just above $15, and if it can hold that level while pushing through resistance near $16, it could trigger further momentum and open the door to new price discovery.
TEM: A High-Short AI Healthcare Play
Tempus AI (NASDAQ: TEM) has quietly been one of the most impressive performers of 2025, with shares up more than 160% year-to-date. The rally is driven by the company's pioneering role in applying artificial intelligence and machine learning to precision medicine.
Tempus's core strength lies in oncology, where it provides genomic profiling, digital pathology, and data-driven insights to support personalized cancer care.
Technically, TEM is approaching a key inflection point. The stock has been consolidating below its all-time high near $91, forming a clear level to watch. With short interest at 25%, a decisive breakout could spark a substantial squeeze, propelling the stock even higher.
Momentum Remains Firmly Intact
Although the broader market may be stretched, momentum remains intact, and high short-interest names are often the biggest beneficiaries in such environments. HIMS, DLO, and TEM each combine strong technical setups with elevated short interest, positioning them for potential squeezes if bullish momentum continues.
While speculation will eventually cool, the current backdrop remains supportive. For investors watching the tape, these three stocks stand out as some of the most intriguing bullish setups in today's market.
This email is a paid sponsorship provided by Timothy Sykes, a third-party advertiser of MarketBeat. Why did I receive this email message?.
Results are not typical and will vary from person to person. Making money trading stocks takes time, timing, proper execution, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk.
If you need help with your account, please don't hesitate to contact MarketBeat's U.S. based support team at contact@marketbeat.com.
If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.
© 2006-2025 MarketBeat Media, LLC. All rights protected.
345 N Reid Place #620, Sioux Falls, South Dakota 57103. United States of America..